Indeed, it's often described as a "wonder drug." That hasn’t stopped a torrent of fat phobia and often frankly hateful ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and ...

Lecanemab is a humanized immunoglobulin gamma 1 monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta.

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

A new study finds that those who responded to the World Trade Center attacks on 9/11 may be at higher risk of early-onset ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Over 2 million people were included in new research to test these drugs against 175 different health outcomes.

You can get a prescription online or in person. Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight ...